Yih-Lin Chung
Department of Radiation Oncology
Koo Foundation Sun Yat-Sen Cancer Center
Taipei
Taiwan
Name/email consistency: high
- Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone. Chung, Y.L., Lee, M.Y., Horng, C.F., Jian, J.J., Cheng, S.H., Tsai, S.Y., Hsieh, C.I., Yen, L.K., Lin, C.Y. Head. Neck (2009)
- Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Chung, Y.L., Jian, J.J., Cheng, S.H., Tsai, S.Y., Chuang, V.P., Soong, T., Lin, Y.M., Horng, C.F. Clin. Cancer Res. (2006)
- Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Chung, Y.L., Jian, J.J., Cheng, S.H., Hsieh, C.I., Tan, T.D., Chang, H.J., Hung, C.F., Horng, C.F., Soong, T., Tsou, M.H. Gynecol. Oncol. (2005)
- Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. Chung, Y.L., Wang, A.J., Yao, L.F. Mol. Cancer Ther. (2004)
- Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Chung, Y.L., Sheu, M.L., Yen, S.H. Int. J. Cancer (2003)
- A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Chung, Y.L., Lee, M.Y., Wang, A.J., Yao, L.F. Mol. Ther. (2003)
- Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer. Chung, Y.L., Sheu, M.L., Yang, S.C., Lin, C.H., Yen, S.H. Int. J. Cancer (2002)
